BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11924833)

  • 1. Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasis.
    Boehncke WH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):231-2. PubMed ID: 11924833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
    Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
    J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model.
    Boehncke WH; Zollner TM; Dressel D; Kaufmann R
    J Cutan Pathol; 1997 Jan; 24(1):1-7. PubMed ID: 9027626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and bacterial superantigens--formal or causal correlation?
    Boehncke WH
    Trends Microbiol; 1996 Dec; 4(12):485-9. PubMed ID: 9004406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
    Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
    J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Superantigens and their possible involvement in psoriasis and other diseases].
    Nemţişor E
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):52-5. PubMed ID: 9455436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases.
    Leung DY; Hauk P; Strickland I; Travers JB; Norris DA
    Br J Dermatol; 1998 Dec; 139 Suppl 53():17-29. PubMed ID: 9990409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermal injection of immunocytes induces psoriasis.
    Wrone-Smith T; Nickoloff BJ
    J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyporesponsiveness of peripheral blood lymphocytes to streptococcal superantigens in patients with guttate psoriasis: evidence for systemic stimulation of T cells with superantigens released from focally infecting Streptococcus pyogenes.
    Tokura Y; Seo N; Ohshima A; Wakita H; Yokote R; Furukawa F; Takigawa M
    Arch Dermatol Res; 1999; 291(7-8):382-9. PubMed ID: 10482006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin?
    Valdimarsson H; Sigmundsdóttir H; Jónsdóttir I
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():21-4. PubMed ID: 9020931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated keratinocytes present bacterial-derived superantigens to T lymphocytes: relevance to psoriasis.
    Nickoloff BJ; Mitra RS; Green J; Shimizu Y; Thompson C; Turka LA
    J Dermatol Sci; 1993 Oct; 6(2):127-33. PubMed ID: 8274458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psoriasis SCID-mouse model].
    Pfeffer J; Kaufmann R; Boehncke WH
    Hautarzt; 2006 Jul; 57(7):603-9. PubMed ID: 16028077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production.
    Herz U; Schnoy N; Borelli S; Weigl L; Käsbohrer U; Daser A; Wahn U; Köttgen E; Renz H
    J Invest Dermatol; 1998 Mar; 110(3):224-31. PubMed ID: 9506440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenotransplantation Model of Psoriasis.
    Di Domizio J; Conrad C; Gilliet M
    Methods Mol Biol; 2017; 1559():83-90. PubMed ID: 28063039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.
    Leung DY; Travers JB; Giorno R; Norris DA; Skinner R; Aelion J; Kazemi LV; Kim MH; Trumble AE; Kotb M
    J Clin Invest; 1995 Nov; 96(5):2106-12. PubMed ID: 7593594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of resident immunocytes in normal and prepsoriatic skin using an ex vivo skin-explant model system.
    Curry JL; Qin JZ; Robinson J; Nickoloff BJ
    Arch Pathol Lab Med; 2003 Mar; 127(3):289-96. PubMed ID: 12653571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulling the trigger on psoriasis.
    Boehncke WH; Dressel D; Zollner TM; Kaufmann R
    Nature; 1996 Feb; 379(6568):777. PubMed ID: 8587600
    [No Abstract]   [Full Text] [Related]  

  • 18. Psoriasis vulgaris--a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis.
    Prinz JC
    Clin Exp Dermatol; 2001 Jun; 26(4):326-32. PubMed ID: 11422184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superantigens in skin diseases.
    Saloga J; Knop J
    Eur J Dermatol; 1999; 9(7):586-90; quiz 591. PubMed ID: 10523743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis--as an autoimmune disease caused by molecular mimicry.
    Valdimarsson H; Thorleifsdottir RH; Sigurdardottir SL; Gudjonsson JE; Johnston A
    Trends Immunol; 2009 Oct; 30(10):494-501. PubMed ID: 19781993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.